Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid. Stew Milne/AP hide caption
Scientists at Pfizer's research and development laboratories in Groton, Conn., worked on the COVID-19 pill called Paxlovid.
Two new drugs are awaiting authorization from the Food and Drug Administration for treating patients with COVID-19, and both may be effective against the omicron variant.
One is made by Merck, the other by Pfizer.
The Merck drug has been in development for years. When the pandemic began, Pfizer's drug didn't exist. The story of its development is another example of how COVID-19 has sped up the drug and vaccine development process.
Pfizer wasn't starting exactly from zero. Mikael Dolsten, Pfizer's chief scientific officer, says that during the SARS outbreak in 2003, company scientists had begun to search for ways to combat that coronavirus.
In particular, they looked for proteins crucial for the virus to replicate once it infected someone.
One viral protein they focused on is called a protease. "We have learned that protease is a key regulator for the virus to unleash its machinery and hijack the human cells," Dolsten says.
Pfizer scientists thought if they could find a compound that would disrupt the protease, it would essentially stop the virus dead in its tracks.
That search petered out when the 2003 SARS outbreak passed. No disease, no market for a drug.
But Dolsten says the knowledge that was gained convinced them that a protease inhibitor would work to corral the coronavirus causing COVID-19.
They made computer models of the viral protease protein and assembled drug candidates that might block it.
"We actually had to design and synthesize some 600 unique chemical compounds," he says.
That was just the start. They had to test each compound to see how well it prevented the virus from infecting cells in the lab. Then they had to determine whether it would do the same thing in animals infected with the coronavirus. They also needed to find a candidate that would remain in someone's body long enough to have the desired antiviral effect. And they wanted to do all this fast.
"We put in place some very aggressive timelines where we made all of this happen over four months to come down to the optimal medicine," Dolsten says.
In the end, the drug developers had a candidate they thought would work. They mixed it in a pill with an old drug called ritonavir that extended the action of the protease inhibitor.
This past July, Pfizer began a study of people infected with the coronavirus who were at high risk of developing severe COVID-19. Half got the drug, called Paxlovid, within three to five days of the onset of symptoms, half a placebo.
Dolsten says the study was halted early because the drug appeared to be working. He says there was nearly a 90% reduction in hospitalization among people taking the new drug, "And 100% protection against death."
A similar analysis for the Merck drug found it lowered the risk of hospitalization or death by 50%. In a subsequent analysis presented to the FDA, the risk reduction fell to 30%, however.
One good thing about these drugs is that because they're pills, they can be taken at home, unlike some current therapies that require an infusion.
Because Pfizer's pill isn't affected by changes in the spike protein, Dolsten says he expects the new drug will work equally well against any variant of the coronavirus, including omicron.
Although Pfizer has not yet published details of its study, researchers seem impressed.
"I think this drug along with the drug from Merck are both very promising antivirals that, as we had predicted early in this pandemic, work when given early in the infectious course," says Stanley Perlman, a microbiologist at the University of Iowa, where he's been working on coronaviruses for decades.
Perlman adds that the key to preventing damage from a coronavirus infection is to stop it from replicating and spreading throughout someone's body.
Protease isn't the only viral protein that might lead to a viable treatment.
"I think there's several other targets in how the virus reproduces," Perlman says. "But the most important thing to think about for all of them is they almost all have to be given very early after infection to really have a role in helping prevent people from progressing to more severe disease."
And since it looks like we'll be living with COVID-19 for a while, drugmakers have an incentive to develop other kinds of drugs to treat the disease.
Pfizer COVID pill benefited from research on SARS : Shots - Health News - NPR
- Is a universal coronavirus vaccine on the horizon? - National Geographic - January 19th, 2022
- Boris Johnson says Englands virus rules will ease next week. - The New York Times - January 19th, 2022
- Coronavirus Roundup: One Year of the Biden COVID-19 Response - GovExec.com - January 19th, 2022
- Thousands in Hong Kong volunteer to adopt hamsters amid COVID-19 fears - Reuters - January 19th, 2022
- Coronavirus spreading like never before in Americas, health agency says - Reuters Canada - January 19th, 2022
- Here are the latest COVID-19 numbers for Wednesday, January 19 - WNEP Scranton/Wilkes-Barre - January 19th, 2022
- How does COVID-19 misinformation compare with other health topics? - Medical News Today - January 19th, 2022
- 538 more coronavirus cases have been reported across Maine - Bangor Daily News - January 19th, 2022
- Is headache a symptom of the omicron COVID variant? - FOX31 Denver - January 19th, 2022
- Omicron won't be the last COVID-19 variant, WHO says - WXYZ - January 19th, 2022
- The cGAS-STING pathway drives type I IFN immunopathology in COVID-19 - Nature.com - January 19th, 2022
- Lesson of the Day: At-Home Coronavirus Tests Are Inaccessible to Blind People - The New York Times - January 19th, 2022
- With many wondering whether Omicron means we're approaching the endemic phase of Covid-19, Fauci cautions it's still too soon to tell - CNN - January 18th, 2022
- Study on 4th COVID vaccine dose shows effectiveness; results against omicron unclear - WXYZ - January 18th, 2022
- Coronavirus in Ohio Monday update: Over 19,500 new cases, 2.4 million total - NBC4 WCMH-TV - January 18th, 2022
- Preparing for the endemic stage of COVID-19: What this looks like - KOIN.com - January 18th, 2022
- White House to offer free COVID tests beginning Wednesday how to get them - KXAN.com - January 18th, 2022
- COVID tests, other public service events on MLK Day in L.A. - Los Angeles Times - January 18th, 2022
- Covid loses 90% of ability to infect within 20 minutes in air study - The Guardian - January 18th, 2022
- Federal at-home COVID-19 tests will be available this week - KRIS Corpus Christi News - January 18th, 2022
- One year later: What symptoms do some COVID-19 patients still have? - WKBW-TV - January 18th, 2022
- Novel coronavirus - Wikipedia - January 16th, 2022
- Virus Outbreak: Covid (Coronavirus) News and Analysis From Jan. 15 - Bloomberg - January 16th, 2022
- Corona Virus SalzburgerLand.com - January 16th, 2022
- Protest in Netherlands against coronavirus measures - Reuters - January 16th, 2022
- For Coronavirus Testing, the Nose May Not Always Be Best - The New York Times - January 16th, 2022
- 14 more Mainers have died and another 1,359 coronavirus cases reported across the state - Bangor Daily News - January 16th, 2022
- Encouraging signs plan B Covid measures may soon be lifted in England - The Guardian - January 16th, 2022
- Experts warn against using Benadryl and milk to treat COVID, despite NC lawmakers post - KXAN.com - January 16th, 2022
- What do we know about the 175,000 people who died of Covid in the UK? - The Guardian - January 16th, 2022
- Coronavirus Data for January 12, 2022 | mayormb - Executive Office of the Mayor - January 16th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 16th, 2022
- Brazil registers 48520 new cases of coronavirus and 175 deaths-health ministry - Reuters - January 16th, 2022
- 3 big Covid misconceptions people still have, according to infectious disease experts - CNBC - January 16th, 2022
- High demand for COVID testing calls Kauai War Memorial Convention Hall to action - KHON2 - January 16th, 2022
- The Covid Race to Watch: Vaccines vs. Variants - The Wall Street Journal - January 16th, 2022
- Hacking a home COVID test by adding a throat swab is a hot topic on Twitter : Goats and Soda - NPR - January 13th, 2022
- Coronavirus Data for January 11, 2022 | mayormb - Executive Office of the Mayor - January 13th, 2022
- Shawnee County Covid Indicator shows cases of coronavirus rising by more than 25% - KSNT News - January 13th, 2022
- Coronavirus in Ohio Thursday update: More than 19,000 new cases reported - NBC4 WCMH-TV - January 13th, 2022
- England cuts coronavirus isolation to 5 days - POLITICO Europe - January 13th, 2022
- COVID-19 in South Dakota: 2,584 total new cases; Death toll rises to 2,544; Active cases at 24,796 - KELOLAND.com - January 13th, 2022
- The Real Reason Americans Aren't Isolating - The Atlantic - January 13th, 2022
- China: Over 20 million in COVID-19 lockdown ahead of 2022 Olympics - NPR - January 13th, 2022
- Coronavirus in Arkansas: another record as over 10,000 new cases reported, 14 more deaths - KNWA - January 13th, 2022
- Utah surge ongoing with 12,990 new COVID-19 cases Thursday - fox13now.com - January 13th, 2022
- Increasing demand for coronavirus tests in Southern Oregon - KDRV - January 13th, 2022
- The Mood in the Capitol Was Already Dark. Then Came Omicron. - The New York Times - January 13th, 2022
- Information for travellers in regards to the corona virus ... - January 10th, 2022
- Corona Virus Update, Currently There Are 179 active ... - January 10th, 2022
- A Surge in Hospitalized Young Children Infected With the Coronavirus - The New York Times - January 10th, 2022
- Coronavirus in Ohio Sunday update: Just over 19,000 new cases and less than 100 new hospitalizations - WKBN.com - January 10th, 2022
- Coronavirus Briefing: A Pandemic of the Forgotten - The New York Times - January 10th, 2022
- COVID-19 surge has overwhelmed some Pa. hospitals and now their workers are getting sick, too - The Philadelphia Inquirer - January 10th, 2022
- Coronavirus: should the UK make vaccination mandatory? - The Guardian - January 10th, 2022
- COVID-19: UK records 141,472 new cases and further 97 coronavirus-related deaths - Sky News - January 10th, 2022
- Flu and Covid at the Same Time? Your 'Flurona' Questions, Answered - The New York Times - January 10th, 2022
- States are scrambling to keep up with an increase in Covid-19 hospitalizations and the demand for testing - CNN - January 10th, 2022
- Health experts want to focus on 'new normal' with the coronavirus | TheHill - The Hill - January 10th, 2022
- Chicago's COVID-19 fight with teachers hangs over a 2nd week - KMTV - 3 News Now - January 10th, 2022
- From delta to omicron, heres how scientists know which coronavirus variants are circulating in the US - KRQE News 13 - January 10th, 2022
- Coronavirus Watch: Oregon breaks COVID-19 case record for the third day running - KDRV - January 7th, 2022
- From delta to omicron, here's how scientists know which coronavirus variants are circulating in the US - The Conversation US - January 7th, 2022
- Understanding flurona: person has the flu and the coronavirus simultaneously - fox2now.com - January 7th, 2022
- Rapid nasal COVID tests feared to be returning false negatives - Axios - January 7th, 2022
- COVID infections hit another daily record in Louisiana as hospitalizations rise - The Advocate - January 7th, 2022
- Coronavirus Data for January 4, 2022 | mayormb - Executive Office of the Mayor - January 7th, 2022
- If you give yourself a COVID test, who tracks the results? - Los Angeles Times - January 7th, 2022
- How TV Shows Are Moving Past the Coronavirus Pandemic - The New York Times - January 7th, 2022
- COVID-19 testing in Massachusetts impacted due to snow - WWLP.com - January 7th, 2022
- Washington to expand access to coronavirus tests, to help contain spread of COVID-19 - KOMO News - January 7th, 2022
- Coronavirus Omicron variant, vaccine, and case numbers in the United States: Jan. 7, 2022 - Medical Economics - January 7th, 2022
- Coronavirus in Ohio Thursday update: Another day of more than 19,000 new cases - WKBN.com - January 7th, 2022
- COVID-19: Did Omicron evolve in mice? - Medical News Today - January 7th, 2022
- Hogan says 10 new hospital-based COVID testing sites to open in Maryland - WTOP - January 7th, 2022
- Outbreak hits Rhode Island hospital after COVID-positive staff called in to work - fox4kc.com - January 7th, 2022
- Swedens king and queen test positive for the coronavirus. - The New York Times - January 5th, 2022
- W.H.O. Downplays Threat From New Virus Variant in France - The New York Times - January 5th, 2022
- Omicron estimated to be 95.4% of coronavirus variants in U.S. - CDC - Reuters - January 5th, 2022
- US COVID cases are on the rise, but this doctor sees hope on the horizon : Coronavirus Updates - NPR - January 5th, 2022